Work

Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in recurrent platinum-resistant ovarian cancer: A real-world study.

Year: 2026

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e17595

Authors: Angeliki Andrikopoulou, Michael Liontos, Anna Svarna, Athanasios Michas, Nikolaos Dedes, Maria Kaparelou, Dimitrios Vlachos, Vasileios Pergialiotis, Dimitrios Haidopoulos, Nikolaos Thomakos, Meletios A. Dimopoulos

Institutions: National and Kapodistrian University of Athens, Alexandra Hospital

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162690344

FWCI:

Cites:

Cited by:

Related to: